Alnylam Pharmaceuticals
ALNY
#639
Rank
S$41.74 B
Marketcap
$322.44
Share price
0.00%
Change (1 day)
63.58%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company